Search
for

    Research 10 of 1000+

    1. Cutaneous manifestations associated with immune checkpoint inhibitors Frontiers in immunology · 2023 · 14 citations
    2. Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution Cancers · 2024 · 3 citations
    3. Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico Actas Dermo-Sifiliográficas · 2021 · 9 citations
    4. [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review Actas Dermo-Sifiliográficas · 2022 · 6 citations
    5. IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY Голова и шея. · 2022
    6. Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma JEADV Clinical Practice · 2026
    7. Cutaneous lupus erythematosus induced by tislelizumab JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024 · 1 citations
    8. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    9. Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors 2016 · 87 citations
    10. Cutaneous toxicities of new treatments for melanoma Clinical & Translational Oncology · 2018 · 25 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →